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Abstract 
Background: To determine mean prothrombin 
time and activated partial thromboplastin time in 
patients of end stage renal disease having normal 
baseline coagulation parameters after hemodialysis. 
Methods:  In this cross sectional study  84 patients 
,16-70 years of age, with end stage renal disease were 
selected. Prothrombin Time (PT) and Activated 
Partial Thromboplastin Time (APTT) were 
performed pre and post dialysis on venous blood 
samples of these patients. 
Results: Mean predialysis PT and APTT 13.33± 0.96 
and 32.45± 1.87 seconds respectively A significant 
increase in the haemostatic parameters post dialysis 
was observed with mean PT and APTT 15.64±3.18 
and 46.54±24.68 seconds respectively with a p-value 
of <0.001 for both parameters. 
Conclusion: Haemostatic parameters i.e 
prothrombin time and activated partial 
thromboplastin time are prolonged after 
haemodialysis in patients with end stage renal 
disease.  
Key Words: Chronic Renal Failure, Hemodialysis, 
Prothrombin time, activated partial thromboplastin 
time. 
Introduction 
Chronic renal failure (CRF) is a growing problem 
worldwide leading to increasing incidence of life 
threatening complications or death.1In Pakistan it has a 
prevalence rate of14%.2 CRF requiring dialysis or end 
stage renal disease is defined as a state of low G.F.R. 
i.e.: 15ml/min per 1.73 meter square.1 The mainstay of 
treatment in this condition is renal replacement 
therapy which includes both kidney transplantation 
and dialysis.3 Kidney transplantation remains the gold 
standard for the treatment of this condition, but 
dialysis (both hemo and peritoneal) is the most 
common and most practiced modality of treatment 
because of high cost of renal transplantation.3,4 Out of 
the two types of dialysis, hemodialysis is most 
commonly practiced.3,5 This process involves removal 
of all the toxic substances from the  plasma like urea 
and it also corrects the electrolytic disturbances in the 
body.4There is a large population of patients 
maintained on dialysis all over the world.4 Although 
beneficial, both types i.e. hemo and peritoneal dialysis 
have their undesirable effects on various blood 
components.4Dialysis can lead to increase in the 
bleeding tendency in the patient.6,7 Unlike  CRF in 
which the bleeding tendency is due to platelet 
functional defects, the patients on dialysis particularly 
hemodialysis tend to have bleeding or thrombotic 
tendency due to disturbances in the function of 
platelets as well as coagulation and fibrinolytic 
systems.6-8The bleeding tendency can also be 
attributed to the use of anticoagulants in the 
procedure.9 This is observed by measuring coagulation 
parameters after dialysis.4 Coagulation parameters i.e.: 
prothrombin time (PT) and activated partial 
thromboplastin time (APTT) are screening tests for 
extrinsic, intrinsic and common pathway clotting 
factors.4 Both PT and APTT tend to increase post 
dialysis.4 According to a previous study activated 
partial thromboplastin time and prothrombin time are 
deranged in 16% and 5%of patients of respectively 
with mean PT of 15.8 ± 2.09 and mean APTT 
derangement 35.4 ± 2.4.3 Therefore monitoring of 
coagulation parameters may help in determining the 
risk of development of bleeding complications  and the 
consequent increasing morbidity rate and therefore 
may be used as a guide for further management of the 
patients.4 
Patients and Methods 
            It was a cross sectional study carried out at Pathology 
             department (haematology section), Fauji Foundation 
Hospital Rawalpindi. Consecutive (non probability) 
sampling was done and the sample size  calculated 
using W.H.O sample size calculator  was 84.All the  
patients with end stage renal disease undergoing 
dialysis having normal PT and APTT, with an  age 
group of  16-70 years were included. Patients on 
anticoagulant drugs and known cases of liver disease 
or other bleeding disorders were excluded. Controls 
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for prothrombin time and partial thromboplastin time 
were prepared by taking pooled plasma of twenty 
apparently healthy adults. A total of 168 venous 
blood samples (2.5ml each) of 84 patients with ESRD  
were collected. The blood samples were collected one 
before starting the dialysis procedure and within two 
hours after the dialysis session. The blood samples 
were transferred without delay (within 2 hours of 
collection) to the coagulation laboratory. The samples 
were centrifuged for fifteen minutes and platelet poor 
plasma was separated. Prothrombin time and 
activated partial thromboplastin time were 
performed on coagulation analyzer within six hours 
of collection in the laboratory. The tests were 
performed according to the standard protocol of test 
recommended by W.H.O.  
 
Results 
There were 23 (27.4%) males and 61 (72.6%) 
females.The age range at the time of study was from 
16 years to 70 years with the mean age of patients was 
47.5 .Seventy five  patients had hemodialysis as part of 
their routine treatment protocol while only 09 patients 
were admitted for dialysis because of exacerbation of 
their uremic symptoms. The mean number of previous 
dialysis was 39.6 while the maximum number of 
previous dialysis by any patient in our study were 283. 
Mean predialysis PT and APTT were 13.33± 0.96 and 
32.45± 1.87 seconds respectively. A significant increase 
in the haemostatic parameters post dialysis was 
observed with mean PT and APTT14.64±3.18 and 
46.54±24.68 seconds respectively with a p-value of 
<0.001 (Figure 1&2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:Difference between mean of PT and APTT 
in renal failure patients before and after 
haemodylasis procedure. 
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Fig2:Differance between PT and APTT in renal failure 
patients before and after HD procedure. 
 
Discussion 
Present study results show a comparable trend in 
mean PT and APTT to a regional study done by Shoaib 
M et al at SIUT Karachi on 61 patients receiving renal 
replacement therapy .The study suggested mean PT 
and APTT to be 15.8±2.09 and 35.4±2.4 respectively.3 
Although comparable to this study in terms of the 
trend of change, there is a significant difference in the 
mean APTT value post dialysis. Mean APTT in our 
study was prolonged as compared to this study. This 
difference may be because of inclusion of patients with 
all the three types of renal replacement therapies 
including renal transplant and peritoneal dialysis in 
their study while our study included only 
haemodialysis patients with no prior renal transplant 
which generally tends to improve the bleeding 
tendency.  
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Ulusoy et al, in 2004, measured the APTT, PT, D-dimer 
and fibrinogen level in ESRD patients undergoing 
conventional HD, before and after HD sessions on 15 
end stage renal disease (ESRD) patients. They found 
increased APTT values and D-dimer, while there was 
a decrease in fibrinogen levels in HD patients’ post-
HD sessions,however insignificant differences in the 
PT levels were seen in HD patients Post-HD sessions 
when compared to pre-HD levels.10 The trends seen in 
this study are comparable to our study. 
Româo JE Jr,in 1997 analyzed post Hemodialysis mean 
PT and APTT  to be 15.0±0.81 and 87.30±27.96 
respectively.11 The prominent increase in mean APTT 
in these patients is probably because of the inclusion of 
patients with already prolonged APTT in pre dialysis 
samples with a mean pre dialysis APTT of 39.70±4.30 
in contrast to our study where pre dialysis mean APTT 
was 32.45±1.87 which is within reference range. 
Alghythan A et al studied 100 patients pre and post 
Hemodialysis for conventional haemostasis 
parameters i.e.PT and APTT. The reported mean PT 
was found to be 23.10±5.69 whereas mean APTT was 
64.64±13.61.12Mohammad MS et al (2008) showed  
mean PT and APTT post dialysis as  23.2sec and 69.8 
sec respectively.4 
The results of the studies mentioned above are 
analogous to the results of our study in terms of 
general tendency of increase in mean PT and APTT 
after dialysis. The striking difference in the post 
dialysis mean of both parameters which are higher 
from our study may be explained by the difference in 
the type and dose of anticoagulant used as different 
anticoagulants in different dosage are preferred in 
various setups and have a significant effect on the 
bleeding tendency and change in coagulation 
parameter post dialysis. In addition the PT and APTT 
in study reported by Mohammad et al was performed 
manually which is subject to observational 
bias.Similarly the individual variation in the condition 
of the patient, reduction in the time duration of the 
dialysis session and decreased number of previous 
dialysis may have caused the discrepancy.  
It has been reported byMaderna et al and Naumnik et 
al that another possible factor that could account for 
the increased haemostasis parameters is the increase in 
the level of tissue factor pathway inhibitor 
(TFPI))which results in the reduced activity of several 
coagulation factors during HD.13,14 
Different results were reported by  Malyszko J et al in 
their study in 2001.The dissimilarity  could be 
explained by the difference in the dose of heparin as 
well as the reduction of the number of HD sessions. 
The difference can also be attributed to the use of more 
sophisticated and detail set of coagulation 
parameters.15 
 
Conclusion 
Coagulation parameters;prothrombin and activated 
partial thromboplastin time are prolonged after 
hemodialysis in patients with end stage renal disease. 
Therefore monitoring of coagulation (prothrombin and 
activated partial thromboplastin time) parameters may 
help in determining the risk of development of 
bleeding complications  and the consequent increasing 
morbidity rate and therefore may be used as a guide 
for further management of their patients.4 
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